OPKO Health (NASDAQ:OPK – Get Free Report) issued its quarterly earnings results on Tuesday. The biotechnology company reported ($0.09) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.09), Briefing.com reports. OPKO Health had a negative return on equity of 13.63% and a negative net margin of 23.94%. The firm had revenue […]